Business Context and Reporting Period
Dyadic International, Inc. (DYAI) filed a Form 8-K on June 23, 2025, reporting a deficiency notice received from The Nasdaq Stock Market LLC. The Company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market.
Key Financial Metrics
This filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on listing compliance status. The filing notes the Company has a history of net losses but does not quantify current financial positions.
Material Changes
The material event reported is the failure to maintain the minimum Market Value of Listed Securities (MVLS) of $35 million required by Nasdaq Listing Rule 5550(b)(2) for the last 30 consecutive business days. This deficiency has no immediate effect on the listing but triggers a compliance period.
Guidance, Outlook, and Risks
- Compliance Timeline: The Company has 180 calendar days, until December 20, 2025, to regain compliance. This requires the MVLS to close at $35 million or more for a minimum of 10 consecutive business days prior to the deadline.
- Management Plan: Management intends to actively monitor MVLS and evaluate options to resolve the deficiency.
- Delisting Risk: If compliance is not met by the deadline, the stock may be subject to delisting. The Company may appeal such a determination, though success is not assured.
- Risk Factors: Forward-looking statements highlight risks including the history of net losses, capital needs, failure to commercialize microbial protein production platforms, competition, and regulatory acceptance.
Investor Verification Checklist
- Verify the current Market Value of Listed Securities (MVLS) to assess proximity to the $35 million threshold.
- Review recent Form 10-K and 10-Q filings for detailed financial performance and capital needs.
- Monitor the Company's stock price volatility and trading volume over the next 180 days.
- Check for any subsequent filings regarding capital raises or strategic actions intended to increase market value.
- Confirm the status of the Company's microbial protein production platforms and commercialization progress.